{"name": "ATCG-Dx",
 "permalink": "atcg-dx",
 "crunchbase_url": "http://www.crunchbase.com/company/atcg-dx",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 6,
 "founded_year": 2009,
 "founded_month": 7,
 "founded_day": 1,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "diagnostics, prenatal, non-invasive, down-syndrome",
 "alias_list": null,
 "email_address": "drorta@gmail.com",
 "phone_number": "+972 (52) 8907856",
 "description": "Non-Invasive Prenatal Diagnostics",
 "created_at": "Mon Oct 31 07:10:45 UTC 2011",
 "updated_at": "Thu Nov 03 20:49:29 UTC 2011",
 "overview": "\u003Cp\u003EStart-up company developing innovative front-line prenatal genetic diagnostic methods, based on Next Generation Sequencing (NGS) technologies. \u003C/p\u003E\n\n\u003Cp\u003EOur product is based on molecular diagnostic method that identifies fetal chromosomal abrasions (and specifically Down-syndrome) by noninvasive procedures, use of maternal blood from an early pregnancy stage.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       75],
      "assets/images/resized/0016/0164/160164v2-max-150x150.jpg"],
     [[250,
       126],
      "assets/images/resized/0016/0164/160164v2-max-250x250.jpg"],
     [[450,
       226],
      "assets/images/resized/0016/0164/160164v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}